Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
    India
    Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
    endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis
    Tuberculosis (TB)
    Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
    India
    Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
    Recent deal offering controlled generics access in limited countries does not go far enough.
    Tuberculosis (TB)
    Access to medicines
    MSF: Governments off track on providing tools to prevent TB, the second biggest infectious disease killer after COVID-19
    South Africa
    MSF: Governments off track on providing tools to prevent TB, the second biggest infectious disease killer after COVID-19
    As the World Health Organization (WHO) convenes a ‘call to action’ tomorrow on the need to scale up access to preventive treatment for tuberculosis (T...
    Tuberculosis (TB)
    Stay up to date
    © Doctors Without Borders
    Privacy Policy